The MF Biocompatible VPP Framework — Monomer-Free Formulation as a Regulatory Engineering Strategy

Abstract

This white paper presents the MF Biocompatible VPP Framework, positioning monomer-free formulation as an engineering strategy for reducing regulatory, toxicological and extractables-related risk in professional manufacturing workflows. Biocompatibility is not only a material label. It depends on formulation architecture, residual species, cleaning, post-processing, final device design, intended use, extraction behaviour and legal-manufacturer validation. MF formulation reduces one relevant risk axis within that broader pathway.